Glyko Biomedical Ltd. other research news

GLYK received a $600,000 Phase II SBIR from the

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE